Chapter Phar 7

Phar 7.14(1)(c) (c) “Product verification” means doing a check of the accuracy and correctness of a product, including drug, strength, formulation, as part of the final check and ensure the product has not reached its expiration or beyond use date.

Phar 7.14(1)(d) (d) “Supervising pharmacist” means the pharmacist licensed in this state, who is responsible for the operations and outcomes of product verification done by a pharmacy product verification technician and ensuring for direct supervision of the pharmacy product verification technician.

Phar 7.14(2) (2) Pharmacy product verification technician qualifications. A pharmacist may delegate the product verification of a prescription or chart order to a pharmacy technician who meets all of the following:

Phar 7.14(2)(b) (b) Completed an accredited pharmacy technician training program or has a minimum of 500 hours of experience in product selection, labeling and packaging.

Phar 7.14(2)(c) (c) Completed a didactic and practical training curriculum approved by the supervising and managing pharmacist that includes training in all of the following:

Phar 7.14(2)(c)1. 1. Elements of correct product including all of the following:

Phar 7.14(2)(c)1.a. a. Drug name.

Phar 7.14(2)(c)1.b. b. Strength.

Phar 7.14(2)(c)1.c. c. Formulation.

Phar 7.14(2)(c)1.d. d. Expiration date.

Phar 7.14(2)(c)1.e. e. Beyond use date.

Phar 7.14(2)(c)2. 2. Common dispensing medication errors and concepts including all of the following:

Phar 7.14(2)(c)2.a. a. Wrong medication.

Phar 7.14(2)(c)2.b. b. Wrong strength.

Phar 7.14(2)(c)2.c. c. Wrong formulation.

Phar 7.14(2)(c)2.d. d. Extra or insufficient quantity.

Phar 7.14(2)(c)2.e. e. Omitted medications if utilizing unit dose or compliance packaging.

Phar 7.14(2)(c)2.f. f. Expired medication.

Phar 7.14(2)(c)2.g. g. Look-alike or sound-alike errors.

Phar 7.14(2)(c)2.h. h. High-alert medications.

Phar 7.14(2)(c)3. 3. Eligible products for pharmacy product verification technician-check-pharmacy technician.

Phar 7.14(2)(c)4. 4. Organizational policies and procedures on reporting of medication errors.

Phar 7.14(2)(c)5. 5. Overview of the medication use process including all of the following:

Phar 7.14(2)(c)5.a. a. Procurement.

Phar 7.14(2)(c)5.b. b. Ordering.

Phar 7.14(2)(c)5.c. c. Dispensing.

Phar 7.14(2)(c)5.d. d. Administration.

Phar 7.14(2)(c)5.e. e. Monitoring.

Phar 7.14(2)(c)6. 6. A practical training designed to assess the competency of the pharmacy technician prior to starting the validation process. The practical training shall include simulation of at least 2 occurrences of each of the following:

Phar 7.14(2)(c)6.a. a. Wrong drug.

Phar 7.14(2)(c)6.b. b. Wrong strength.

Phar 7.14(2)(c)6.c. c. Wrong formulation.

Phar 7.14(2)(c)6.d. d. Omitted medication, if utilizing unit dose or compliance packaging.

Phar 7.14(2)(d) (d) Completed the following validation process:

Phar 7.14(2)(d)1. 1. The pharmacy technician being validated shall make a product verification on the work of a pharmacist or another pharmacy technician for accuracy and correctness of a minimum of 500 product verifications over a minimum of 5 separate days and achieve an accuracy rate of at least 99.8%.

Phar 7.14(2)(d)2. 2. A pharmacist shall audit 100% of the product verifications made by the pharmacy technician during the validation process.

Phar 7.14(2)(e) (e) Notwithstanding pars. (b) to (d), an individual who completed the board’s pilot program validation process between October 1, 2016 and September 30, 2019, meets the pharmacy product verification technician qualifications unless the individual fails to meet the quality assurance standards under sub. (4).

Phar 7.14(3) (3) Eligible product.

Phar 7.14(3)(a) (a) Institutional pharmacies. The pharmacy product verification technician may do the product verification in an institutional pharmacy if all of the following requirements are met:

Phar 7.14(3)(a)1. 1. The source drug product or device is in an original package from a manufacturer or a licensed pharmacist has ensured that the source package is labeled with the correct name, strength, form, control or lot number, and beyond use or expiration date.

Phar 7.14(3)(a)2. 2. A drug utilization review performed by a pharmacist prior to dispensing.

Phar 7.14(3)(a)3. 3. The drug product will be administered by an individual authorized to administer medications at the institution where the medication is administered.

Phar 7.14(3)(b) (b) Community pharmacies. The pharmacy product verification technician may do the product verification in a community pharmacy if all of the following requirements are met:

Phar 7.14(3)(b)1. 1. The source drug product or device is in an original package from a manufacturer or a licensed pharmacist has ensured that the source package is labeled with the correct name, strength, form, control or lot number, and beyond use or expiration date.

Phar 7.14(3)(b)2. 2. A drug utilization review performed by a pharmacist prior to dispensing.

Phar 7.14(3)(b)3. 3. A non-pharmacist shall be able to check the accuracy of the medication by one of the following:

Phar 7.14(3)(b)3.a. a. The drug product or device is in the original packaging from a manufacturer.

Phar 7.14(3)(b)3.b. b. The drug product or device includes a description of the drug product or device on the prescription label.

Phar 7.14(3)(b)3.c. c. The pharmacist shows the patient or patient’s agent the drug product or device and provides a monograph that includes a description of the drug product or device.

Phar 7.14(4) (4) Quality assurance.

Phar 7.14(4)(a) (a) A minimum of 5% of each pharmacy product verification technician’s verifications shall be audited by a licensed pharmacist. The accuracy of each pharmacy product verification technician shall be tracked individually.

Phar 7.14(4)(b) (b) A record of each pharmacy product verification technician-check-pharmacy technician audit shall include all of the following:

Phar 7.14(4)(b)1. 1. Name of the pharmacy product verification technician.

Phar 7.14(4)(b)2. 2. Total number of product verifications performed.

Phar 7.14(4)(b)3. 3. Number of product verifications audited by the pharmacist.

Phar 7.14(4)(b)4. 4. Percentage of product verifications audited by pharmacist.

Phar 7.14(4)(b)5. 5. Percentage of accuracy.

Phar 7.14(4)(b)6. 6. Number of product verification errors identified.

Phar 7.14(4)(b)7. 7. Type of error under sub. (2) (c) 2. a. to c. and e.

Phar 7.14(4)(c) (c) On a quarterly basis, the supervising pharmacist shall perform an assessment of each pharmacy product verification technician’s previous 12 months accuracy and correctness of pharmacy product verifications including a review of the quality assurance log.

Phar 7.14(4)(d) (d) A pharmacy product verification technician shall be revalidated if the individual fails to maintain a product verification accuracy rate of 99.8% based on the quarterly assessment of the previous 12 months or has not performed verifications within the last 6 months.

Phar 7.14(5) (5) Policies and procedures. Each pharmacy shall maintain policies, procedures, and training materials for the pharmacy product verification by technicians which shall be made available to the board upon request.

Phar 7.14(6) (6) Records.

Phar 7.14(6)(a) (a) Each pharmacy shall maintain for 5 years the following records:

Phar 7.14(6)(a)1. 1. All validation records of each pharmacy product verification technician that include the dates that the validation occurred, the number of product verifications performed, the number of product verification errors, and overall accuracy rate.

Phar 7.14(6)(a)2. 2. Documentation indicating accepting responsibility for compliance with this section, signed and dated by both the managing pharmacist and supervising pharmacist, indicating the name of the supervising pharmacist, and the dates the supervision responsibilities begin and end.

Phar 7.14(6)(a)3. 3. Quality assurance audits and quarterly assessments.

Phar 7.14(6)(b) (b) Records shall be made available to the board upon request.

Phar 7.14 History History: CR 19-145: cr. Register December 2020 No. 780, eff. 1-1-21; corrections in (2) (e) made under ss. 13.92 (4) (b) 12. and 35.17, Stats., and correction in (2) (c) 6. (intro.), (4) (b) 7. made under s. 35.17, Stats., Register December 2020 No. 780; EmR2303: emerg. am. (title), (1) (a), (b), (d), (2) (intro.), r. (2) (a), am. (2) (b), (c) 3., 6., (d) 1., 2., (e), (3) (a) (intro.), (b), (4) (a), (b) (intro.), 1., (c), (d), (5), (6) (a) 1., 2., eff. 2-3-23; CR 23-072: r. and recr. (title), am. (1) (a), (b), (d), (2) (intro.), r. (2) (a), am. (2) (b), (c) 3., 6., (d) 1., 2., (e), (3) (a) (intro.), (b) (intro.), 1., (c), (d), (5), (6) (a) 1., 2. Register August 2024 No. 824, eff. 9-1-24.

Phar 7.15 Phar 7.15 Consumer disclosures.

Phar 7.15(1) (1) Each pharmacy shall post in a prominent place and maintain the consumer disclosures required in ss. 450.13 (5m) and 450.135 (8m), Stats.

Phar 7.15(2) (2) A link to the 100 most commonly prescribed generic drug product equivalents as determined by the board, shall be maintained on the department’s website as required in s. 450.13 (5m) (b), Stats.

Phar 7.15 Note Note: Copies of the required consumer disclosures are located on the Department of Safety and Professional Service’s website: https://dsps.wi.gov.

Phar 7.15(3) (3) Pursuant to s. 450.13 (5m) (c), Stats., each pharmacy shall maintain and make available to the public a list of the drugs from the list in sub. (2) that are available for purchase at that pharmacy. The list shall be updated monthly, with all of the following information included:

Phar 7.15(3)(a) (a) Brand name.

Phar 7.15(3)(b) (b) Generic equivalent drugs and biological products.

Phar 7.15(3)(c) (c) Interchangeable biological products.

Phar 7.15(3)(d) (d) Retail price.

Phar 7.15(4) (4) The list required under sub. (3) may differ depending on whether the drugs on the list from sub. (2) are available for purchase at a specific pharmacy.

Phar 7.15 History History: CR 23-015: cr. Register April 2024 No. 820, eff. 5-1-24; correction in (2) made under s. 35.17, Stats., Register April 2024 No. 820.

subch. II of ch. Phar 7 Subchapter II — Central Shared Services

Phar 7.30 Phar 7.30 Definitions. In this subchapter:

Phar 7.30(1) (1) “Central shared services pharmacy” means a pharmacy licensed in this state acting as an agent of an originating pharmacy.

Phar 7.30(2) (2) “Labeling pharmacy” means the central shared services pharmacy or originating pharmacy which is responsible for product verification under s. Phar 7.07 (1) (a) and (b).

Phar 7.30(3) (3) “Originating pharmacy” means a pharmacy licensed in this state that uses a central shared services pharmacy.

Phar 7.30 History History: CR 19-145: cr. Register December 2020 No. 780, eff. 1-1-21.

Phar 7.31 Phar 7.31 Requirements. An originating pharmacy may use a central shared services pharmacy only pursuant to the following requirements:

Phar 7.31(1) (1) The central shared services pharmacy either has the same owner as the originating pharmacy or has a written contract with the originating pharmacy outlining the services to be provided and the responsibilities of each pharmacy in fulfilling the terms of the contract.

Phar 7.31(2) (2) The central shared services pharmacy shall maintain a record of all originating pharmacies, including name, address and DEA number that it provides services to.